Market News & Trends
Lonza and InduPro Announce Licensing Agreement to Advance Next-Generation ADC Therapeutics
Basel, Switzerland, – Lonza and InduPro, a biotechnology company pioneering next-generation therapeutics through the targeted proximity of cell-surface proteins, today announced a new licensing agreement to…
ViiV Healthcare advances paediatric HIV regulatory submissions with FDA Priority Review for Tivicay PD and EMA validation of marketing application for Tivicay
London, – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug…
Alcami Expands Quality, Packaging, and Storage Capabilities at Tennessee Facility
Wilmington, North Carolina,– Alcami Corporation, a leading contract development and manufacturing organization (CDMO), today announced a series of strategic and operational investments at its Tennessee…
Mabion reactivates MabionCD20 through rare disease collaboration with Oddifact
Mabion S.A., a Polish biotechnology company, has signed a letter of intent (LoI) with French TechDev company Oddifact SAS to evaluate and advance MabionCD20 for…
LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody
LONDON, United Kingdom — LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise therapeutic antibodies, today announced a…
InnoGI Technologies Launches TIM Cell to Bridge the Gap Between Bioaccessibility and Absorption
Delft, The Netherlands, InnoGI Technologies announced the launch of TIM Cell, a novel apparent permeability service designed specifically to work with TIM intestinal fluids (TIF).…
Aptar Active Material Science Secures USPTO Allowance for N-Sorb Technology, Establishing First-of-Its-Kind Packaging-Delivered Approach to Nitrosamine Risk Mitigation
Auburn, Alabama, Aptar Active Material Science, part of AptarGroup, Inc. and a global leader in active material science solutions, has announced a significant intellectual property…
Quantum BioPharma Ltd. Advances Proprietary Therapy for Multiple Sclerosis Treatment
Quantum BioPharma’s LUCID-MS program is built around the unmet need for MS therapies capable of directly protecting or restoring myelin integrity that affects the loss…
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases
FREDERICK, MD, – Cartesian Therapeutics, Inc., a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced a strategic licensing agreement with WestGene…
Recipharm and Fusix Biotech advance novel oncolytic virus platform
Recipharm, a leading global contract development and manufacturing organization (CDMO), today announced a strategic collaboration with Fusix Biotech to support the development and manufacturing of…
Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression
London, UK – Engitix Ltd. (“Engitix”), a biotechnology company pioneering extracellular matrix (ECM)-driven drug discovery, today announced a strategic research collaboration and option agreement with…
Stevanato Group Introduces Deora, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
Stevanato Group S.p.A., a leading global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries, today introduced…
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
NOTTINGHAM, UK – Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed using artificial intelligence (AI) - a…
CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network
MONTREAL, CANADA – CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a Strategic Partnership with Sonic Healthcare USA, Inc. to launch the…
Lonza Advances Integrated DNA to IND Programs Through Acceleration, De Risking, and Innovation
Basel, Switzerland, – Lonza, the world’s leading CDMO, announced today a strengthening of its biologics development services with an enhanced preclinical development offering designed to help…
Deep Science Ventures and Medicines Discovery Catapult Partner to Accelerate Next Generation Brain Treatments
LONDON – Deep Science Ventures , a UK-based deeptech venture creator, and Medicines Discovery Catapult (MDC), a life sciences service dedicated to turning drug discovery into…
Microbot Medical Secures the First Healthcare System in North Carolina to Adopt the LIBERTY Endovascular Robotic System
HINGHAM, Mass., -- Microbot Medical Inc., developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that it has secured its first North Carolina-based…
Spherix Data Reveals Explosive Demand for Wegovy Pill as $100B Weight Loss Race Intensifies
EXTON, PA, Spherix, the leading independent market intelligence and advisory firm for the global life sciences industry, announced new research highlighting how the race to…
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers
Houston, Texas and Tuebingen, Germany, Immatics”, the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced…
Nouscom Receives U.S. FDA Fast Track Designation for NOUS-209, a Novel Immunotherapy for the Prevention of Lynch Syndrome-Associated Cancers
BASEL, Switzerland – Nouscom, a clinical-stage biotech company developing next-generation immunotherapies to treat cancer at all stages, from early cancer interception to late-stage metastatic disease,…
